In Sudan, one paper reported 81 IgM-based dengue-confirmed patients in 2010, classifying 58% of them as DHF and 11% as DSS using the WHO criteria (Abdallah et al., 2012). This evidence concerns the gene CD40LG and Dengue hemorrhagic fever.